Foundation Fighting Blindness Retinal Degeneration Fund - 09 Dec 2025 SCHEDULE 13D/A Report for Opus Genetics, Inc. Common Stock, $0.0001 par value per share (IRD)

Filing Manager
Foundation Fighting Blindness Retinal Degeneration Fund
Reporting Manager
Foundation Fighting Blindness Retinal Degeneration Fund
Security
Opus Genetics, Inc. Common Stock, $0.0001 par value per share
Symbol
IRD
Shares outstanding
68.7M shares
Disclosed Ownership
5.49M shares
Ownership
8%
Form type
SCHEDULE 13D/A
Filing time
11 Dec 2025, 20:52:21 UTC
Date of event
09 Dec 2025
Previous filing
06 May 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Foundation Fighting Blindness Retinal Degeneration Fund 8% 5.49M 0 5.49M /s/ Russell Kelley Russell Kelley, Managing Director 0002042266
Foundation Fighting Blindness, Inc. 8% 5.49M 0 5.49M /s/ Jason Menzo Jason Menzo, Chief Executive Officer 0002042532